title: Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests.
abstract: Bladder cancer is one of the most prevalent cancers worldwide, but the treatment and management of this disease can be very successful if the disease is detected early. The development of molecular assays that could diagnose bladder cancer accurately, and at an early stage, would be a significant advance. Ideally, such molecular assays would be applicable to non-invasively obtained body fluids, and be designed not only for diagnosis but also for monitoring disease recurrence and response to treatment. In this article, we assess the performance of current diagnostic assays for bladder cancer and discuss some of the emerging biomarkers that could be developed to augment current bladder cancer detection strategies.
authors.affiliation: Cancer Research Institute, MD Anderson Cancer Center Orlando, 6900 Lake Nona Blvd, Orlando, FL 32827, USA. steven.goodison@orlandohealth.com
authors.forename: Steve
authors.initials: S
authors.lastname: Goodison
authors.forename: Charles J
authors.initials: CJ
authors.lastname: Rosser
authors.forename: Virginia
authors.initials: V
authors.lastname: Urquidi
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood* / Q000652:urine*; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000652:urine
chemical_list: D014408:Biomarkers, Tumor